Cancer Research Horizons Biomarkers Summit

Visit us at booth #NA

Learn about our new 5-letter sequencing technology – duet multiomics solution +modC – and discover the combinatorial power of genetics and epigenetics.

17 November 2023
to 17 November 2023

Cancer Research UK Centre, Manchester

About the event

The purpose of this Biomarkers Commercialisation Summit is to support researchers of the CRUK Biomarker Centre and the Manchester Cancer Research Centre to explore pathways to translate their biomarkers and diagnostics research towards clinical use and market adoption.   

Considerations for Commercialising Multimodal Diagnostics

Paidi Creed

Senior Director, Computational Technologies

biomodal

11.45am - 12.15pm

Presentation abstract

Review specific considerations for multimodal software-based diagnostics.

Panel Discussion: Taking a Diagnostic to Market - Industry Perspective

Paidi Creed

Senior Director, Computational Technologies

biomodal

3.00pm - 3.45pm

Presentation abstract

The aim of this panel is to provide practical insights for researchers considering or already engaged in research translation and technology licensing, highlighting the opportunities and challenges associated with this path.

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

Related resources

Attending from biomodal

Senior Director of Computational Technologies
Cancer Research Horizons Biomarkers Summit 17Nov23

Get in touch

Cambridge Epigenetix is now biomodal